Switch theme
Sign up to access all valuation multiples
Senzime AB, a medical technology company, develops, manufactures, and markets patient monitoring systems for monitoring patients. Its solutions are designed to ensure maximum patient benefit, reduce complications associated with surgery and anesthesia, and decrease healthcare costs. Its products include TetraGraph and TetraSens, ExSpiron, TetraSens Pediatric, and TetraConnect. Its geographical segments include Sweden, the United States of America which generates key revenue, Europe/Oceania, and Asia.
1999
52
LTM Revenue $7.5M
LTM EBITDA -$8.9M
$43.0M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Senzime has a last 12-month revenue of $7.5M and a last 12-month EBITDA of -$8.9M.
In the most recent fiscal year, Senzime achieved revenue of $5.8M and an EBITDA of -$9.5M.
Senzime expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Senzime valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $3.6M | $5.8M | XXX | XXX | XXX |
| Gross Profit | -$0.4M | $0.8M | XXX | XXX | XXX |
| Gross Margin | -12% | 14% | XXX | XXX | XXX |
| EBITDA | -$11.5M | -$9.5M | XXX | XXX | XXX |
| EBITDA Margin | -324% | -163% | XXX | XXX | XXX |
| Net Profit | -$13.2M | -$13.3M | XXX | XXX | XXX |
| Net Margin | -371% | -229% | XXX | XXX | XXX |
| Net Debt | n/a | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Senzime's stock price is SEK 4 (or $0).
Senzime has current market cap of SEK 511M (or $50.7M), and EV of SEK 433M (or $43.0M).
See Senzime trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $43.0M | $50.7M | XXX | XXX | XXX | XXX | $-0.08 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Senzime has market cap of $50.7M and EV of $43.0M.
Senzime's trades at 5.7x LTM EV/Revenue multiple, and -4.8x LTM EBITDA.
Analysts estimate Senzime's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Senzime and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $43.0M | XXX | XXX | XXX |
| EV/Revenue | 7.4x | XXX | XXX | XXX |
| EV/EBITDA | -4.5x | XXX | XXX | XXX |
| P/E | -4.3x | XXX | XXX | XXX |
| P/E/Growth | n/a | XXX | XXX | XXX |
| EV/FCF | -3.4x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpSenzime's NTM/LTM revenue growth is 105%
Senzime's revenue per employee for the last fiscal year averaged $0.1M, while opex per employee averaged $0.3M for the same period.
Over next 12 months, Senzime's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Senzime's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Senzime and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 64% | XXX | XXX | XXX | XXX |
| EBITDA Margin | -163% | XXX | XXX | XXX | XXX |
| EBITDA Growth | -18% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | -59% | XXX | XXX | XXX | XXX |
| Revenue per Employee | $0.1M | XXX | XXX | XXX | XXX |
| Opex per Employee | $0.3M | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | 158% | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | 65% | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | 38% | XXX | XXX | XXX | XXX |
| Opex to Revenue | 247% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Senzime acquired XXX companies to date.
Last acquisition by Senzime was XXXXXXXX, XXXXX XXXXX XXXXXX . Senzime acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Senzime founded? | Senzime was founded in 1999. |
| Where is Senzime headquartered? | Senzime is headquartered in Sweden. |
| How many employees does Senzime have? | As of today, Senzime has 52 employees. |
| Who is the CEO of Senzime? | Senzime's CEO is Mr. Philip Siberg. |
| Is Senzime publicy listed? | Yes, Senzime is a public company listed on STO. |
| What is the stock symbol of Senzime? | Senzime trades under SEZI ticker. |
| When did Senzime go public? | Senzime went public in 2008. |
| Who are competitors of Senzime? | Similar companies to Senzime include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of Senzime? | Senzime's current market cap is $50.7M |
| What is the current revenue of Senzime? | Senzime's last 12-month revenue is $7.5M. |
| What is the current EBITDA of Senzime? | Senzime's last 12-month EBITDA is -$8.9M. |
| What is the current EV/Revenue multiple of Senzime? | Current revenue multiple of Senzime is 5.7x. |
| What is the current EV/EBITDA multiple of Senzime? | Current EBITDA multiple of Senzime is -4.8x. |
| What is the current revenue growth of Senzime? | Senzime revenue growth between 2023 and 2024 was 64%. |
| Is Senzime profitable? | Yes, Senzime is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
